Applied Therapeutics, Inc. (APLT) SEC filings
APLT SEC filings moved a median of +0.78% by the close. APLT SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the APLT overview →
56 measured APLT SEC filing events.
Where these APLT SEC filings landedvs 48 measured APLT SEC filing reactions
| Middle 50% of APLT SEC filing reactions | -2.91% to +3.81% |
|---|---|
| Median reaction (to close) | +0.78% |
| Measured reactions | 48 |
Point-in-time · zero look-ahead
Half of the 48 APLT SEC filing events with a measured close landed between -2.91% and +3.81%; 60% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G Applied Therapeutics, | SEC filing · Form 15-12G | — | — | |
| Form EFFECT Applied Therapeutics, | SEC filing · Form EFFECT | — | — | |
| Form 8-K Applied Therapeutics, For: Feb 03 | SEC filing · Form 8-K | — | — | |
| Form POS AM Applied Therapeutics, | SEC filing · Form POS | — | — | |
| Form S-8 POS Applied Therapeutics, | SEC filing · Form S-8 | — | — | |
| Form 8-K Applied Therapeutics, For: Dec 11 | SEC filing · Form 8-K | -11.96% | -8.29% | |
| Form 8-K Applied Therapeutics, For: Nov 20 | SEC filing · Form 8-K | +2.13% | +3.92% | |
| Form 10-Q Applied Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +1.63% | — | |
| Form 8-K Applied Therapeutics, For: Nov 09 | SEC filing · Form 8-K | +1.63% | — | |
| Form 8-K Applied Therapeutics, For: Aug 29 | SEC filing · Form 8-K | -0.20% | +2.18% | |
| Form 8-K Applied Therapeutics, For: Aug 13 | SEC filing · Form 8-K | -0.58% | +8.86% | |
| Form 10-Q Applied Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.58% | +8.86% | |
| Form 8-K Applied Therapeutics, For: Aug 13 | SEC filing · Form 8-K | -0.58% | +8.86% | |
| Form 8-K Applied Therapeutics, For: Aug 11 | SEC filing · Form 8-K | -0.02% | — | |
| Form 8-K Applied Therapeutics, For: Jun 15 | SEC filing · Form 8-K | +2.94% | +3.09% | |
| Form 8-K Applied Therapeutics, For: Jun 09 | SEC filing · Form 8-K | +1.07% | +0.00% | |
| Form 10-Q Applied Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +2.23% | +13.39% | |
| Form 8-K Applied Therapeutics, For: May 13 | SEC filing · Form 8-K | +2.23% | +13.39% | |
| Form ARS Applied Therapeutics, For: Dec 31 | SEC filing · Form ARS | -1.76% | +1.50% | |
| Form DEF 14A Applied Therapeutics, For: Jun 09 | SEC filing · Form DEF | -1.76% | +1.50% | |
| Form DEFA14A Applied Therapeutics, | SEC filing · Form DEFA14A | -1.76% | +1.50% | |
| Form S-8 Applied Therapeutics, | SEC filing · Form S-8 | -0.43% | +0.78% | |
| Form PRE 14A Applied Therapeutics, For: Jun 09 | SEC filing · Form PRE | -0.26% | -3.59% | |
| Form 10-K Applied Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -0.71% | -10.08% | |
| Form 8-K Applied Therapeutics, For: Apr 14 | SEC filing · Form 8-K | -0.71% | -10.08% | |
| Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission | Press release | -2.16% | -2.38% | |
| Form NT 10-K Applied Therapeutics, For: Dec 31 | SEC filing · Form NT | -2.16% | -2.38% | |
| Form 8-K Applied Therapeutics, For: Feb 07 | SEC filing · Form 8-K | +2.69% | -3.14% | |
| Form 8-K Applied Therapeutics, For: Dec 19 | SEC filing · Form 8-K | +2.90% | -7.36% | |
| Form 8-K Applied Therapeutics, For: Dec 06 | SEC filing · Form 8-K | +4.74% | +6.90% | |
| Form 8-K Applied Therapeutics, For: Dec 02 | SEC filing · Form 8-K | -4.02% | -2.87% | |
| Form 8-K Applied Therapeutics, For: Nov 27 | SEC filing · Form 8-K | -1.50% | -6.88% | |
| Form 10-Q Applied Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.41% | +0.93% | |
| Form 8-K Applied Therapeutics, For: Nov 07 | SEC filing · Form 8-K | -0.41% | +0.93% | |
| Form 10-Q Applied Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.96% | -1.12% | |
| Form 8-K Applied Therapeutics, For: Aug 07 | SEC filing · Form 8-K | +0.96% | -1.12% | |
| Form 8-K Applied Therapeutics, For: Jun 06 | SEC filing · Form 8-K | +0.11% | +3.78% | |
| Form 10-Q Applied Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -1.77% | -3.55% | |
| Form 8-K Applied Therapeutics, For: May 09 | SEC filing · Form 8-K | -1.77% | -3.55% | |
| Form EFFECT Applied Therapeutics, | SEC filing · Form EFFECT | +1.29% | +0.71% | |
| Form ARS Applied Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.00% | +0.45% | |
| Form DEF 14A Applied Therapeutics, For: Jun 06 | SEC filing · Form DEF | +0.00% | +0.45% | |
| Form DEFA14A Applied Therapeutics, | SEC filing · Form DEFA14A | +0.00% | +0.45% | |
| Form 8-K Applied Therapeutics, For: Apr 09 | SEC filing · Form 8-K | +1.39% | +2.39% | |
| Form PRE 14A Applied Therapeutics, For: Jun 06 | SEC filing · Form PRE | +0.40% | -3.01% | |
| Form 8-K Applied Therapeutics, For: Mar 28 | SEC filing · Form 8-K | +3.41% | +5.32% | |
| Form S-3 Applied Therapeutics, | SEC filing · Form S-3 | +3.83% | +3.53% | |
| Form D Applied Therapeutics, | SEC filing · Form D | +8.38% | +8.38% | |
| Form 8-K Applied Therapeutics For: Mar 11 | SEC filing · Form 8-K | +11.09% | +6.55% | |
| Form 10-K Applied Therapeutics For: Dec 31 | SEC filing · Form 10-K | +1.95% | +0.78% | |
| Form 8-K Applied Therapeutics For: Mar 06 | SEC filing · Form 8-K | +1.95% | +0.78% | |
| Form 8-K Applied Therapeutics For: Feb 27 | SEC filing · Form 8-K | +5.20% | -0.70% | |
| Form 8-K Applied Therapeutics For: Feb 15 | SEC filing · Form 8-K | -1.75% | +19.05% | |
| Form 8-K Applied Therapeutics For: Jan 04 | SEC filing · Form 8-K | +2.46% | -14.77% | |
| Form 8-K Applied Therapeutics For: Jan 03 | SEC filing · Form 8-K | -8.49% | -4.78% | |
| Form 8-K Applied Therapeutics For: Dec 28 | SEC filing · Form 8-K | +10.65% | +7.69% |
Keep exploring
More APLT: earnings → · analyst actions → · APLT overview →